CCR2 antagonists (Bristol-Myers Squibb)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCCR2 antagonists (Bristol-Myers Squibb)
Drug Alias NameBMS-747634BMS-A
ClassificationSmall molecules
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsInflammationMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsInflammationMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A